Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.

BACKGROUND: A clinical diagnosis of familial hypercholesterolaemia (FH) is often made in the absence of tendon xanthomata (TX), which are not usually present before the fourth decade of life. The prognosis of treated non-xanthomatous (TX-) FH is uncertain and the objective of this study was to comp...

Bibliográfalaš dieđut
Váldodahkkit:	Neil, H, Huxley, R, Hawkins, M, Durrington, P, Betteridge, D, Humphries, SE
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2003

Geahča maid

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
Dahkki: Neil, H, et al.
Almmustuhtton: (2005)

Mycosis fungoides with xanthomatization
Dahkki: Chao-Jen Shih
Almmustuhtton: (2012-03-01)

Localized xanthomatization in Becker's nevus
Dahkki: Yi-Chiun Tsai
Almmustuhtton: (2016-12-01)

Urinary bladder xanthomatous cystitis
Dahkki: Shrenik J Shah, et al.
Almmustuhtton: (2017-01-01)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.
Dahkki: Neil, A, et al.
Almmustuhtton: (2008)

Microcystic Adnexal Carcinoma with Xanthomatous Reaction
Dahkki: Kazuyasu Fujii, et al.
Almmustuhtton: (2021-04-01)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
Dahkki: Neil, A, et al.
Almmustuhtton: (2008)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
Dahkki: Neil, H, et al.
Almmustuhtton: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
Dahkki: Neil, H, et al.
Almmustuhtton: (2004)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
Dahkki: Neil, A, et al.
Almmustuhtton: (2003)

Xanthomatous hypophysitis behaving like pituitary adenoma
Dahkki: MA Xiao⁃li, et al.
Almmustuhtton: (2023-07-01)

Xanthomatous nevus: A potential new entity
Dahkki: Marialuisa Corbeddu, MD, et al.
Almmustuhtton: (2021-05-01)

Xanthomatous meningioma; a rare histological variant
Dahkki: Jasim Al-Diab, et al.
Almmustuhtton: (2018-12-01)

Atypical proliferating epidermoid cyst with xanthomatous reaction
Dahkki: Paula Beers, MD, et al.
Almmustuhtton: (2019-03-01)

A case report of palmar xanthoma with xanthomatous neuropathy
Dahkki: Hyun Yi Lee, et al.
Almmustuhtton: (2021-09-01)

Monomorphic xanthomatous type of xanthogranuloma: a rare entity
Dahkki: Devi Nivean, Pratheeba, et al.
Almmustuhtton: (2017-07-01)

A xanthomatous eruption in a patient with jaundice and constitutional symptoms
Dahkki: Laura Serra-García, et al.
Almmustuhtton: (2022-01-01)

Xanthomatous Hypophysitis: A Case Report and Comprehensive Literature Review
Dahkki: Jianyu Zhu, et al.
Almmustuhtton: (2021-10-01)

Xanthomatous hypophysitis: A rare case report with review of literature
Dahkki: Hema Kini, et al.
Almmustuhtton: (2019-01-01)

Recurrent Schowannoma With Extensive Xanthomatous Changes: A Case Report
Dahkki: Hedieh Moradi Tabriz, et al.
Almmustuhtton: (2021-10-01)

Generalized Eruptive Histiocytosis or Juvenile Xanthogranuloma: A Clinicopathological Conundrum of Coexistence or Xanthomatization
Dahkki: Aravind Baskar Murthy, et al.
Almmustuhtton: (2024-08-01)

Steroid Responsive Xanthomatous Hypophysitis Associated with Autoimmune Thyroiditis: A Case Report
Dahkki: Ji Young Joung, et al.
Almmustuhtton: (2013-03-01)

Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study.
Dahkki: Neil, H, et al.
Almmustuhtton: (2000)

Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study.
Dahkki: Huxley, R, et al.
Almmustuhtton: (2003)

Two distinct case reports with foamy cell and differential diagnosis: Xanthomatous meningioma and review of literature
Dahkki: Emel Çakır, et al.
Almmustuhtton: (2021-06-01)

Xanthomatous cutaneous Rosai-Dorfman disease with overlapping features of IgG4-related disease
Dahkki: Alexander Gitin, BS, et al.
Almmustuhtton: (2022-11-01)

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
Dahkki: Neil, H, et al.
Almmustuhtton: (1999)

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.
Dahkki: Humphries, SE, et al.
Almmustuhtton: (2006)

Xanthomatous Hypophysitis Presenting in an Adolescent Girl: A Long-Term Follow-Up of a Rare Case and Review of the Literature
Dahkki: Jeanne Sze Lyn Wong, MBBS, MRCPH, et al.
Almmustuhtton: (2021-05-01)

Statins and familial hypercholesterolaemia.
Dahkki: Neil, A, et al.
Almmustuhtton: (2009)

The utility of DNA-based testing in patients with familial hypercholesterolaemia in the UK
Dahkki: Humphries, SE, et al.
Almmustuhtton: (2005)

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
Dahkki: Minhas, R, et al.
Almmustuhtton: (2009)

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study.
Dahkki: Neil, H, et al.
Almmustuhtton: (2010)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Dahkki: Marks, D, et al.
Almmustuhtton: (2000)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Dahkki: Marks, et al.
Almmustuhtton: (2000-01-01)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
Dahkki: Seed, M, et al.
Almmustuhtton: (2009)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
Dahkki: Seed, M, et al.
Almmustuhtton: (2009)

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.
Dahkki: Marks, D, et al.
Almmustuhtton: (2003)

CTCA in children with severe heterozygous familial hypercholesterolaemia: Screening for subclinical atherosclerosis
Dahkki: M. Doortje Reijman, et al.
Almmustuhtton: (2024-03-01)

Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.
Dahkki: Arambepola, C, et al.
Almmustuhtton: (2007)